查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
腦膜炎診斷測試市場規模,份額和趨勢分析報告：按測試類型（乳膠凝集試驗,側向流動試驗,PCR試驗,ELISA試驗,培養試驗）,最終用戶,地區細分市場預測2023-2030
市場調查報告書
商品編碼
1171099

腦膜炎診斷測試市場規模,份額和趨勢分析報告：按測試類型（乳膠凝集試驗,側向流動試驗,PCR試驗,ELISA試驗,培養試驗）,最終用戶,地區細分市場預測2023-2030

Meningitis Diagnostic Testing Market Size, Share & Trends Analysis Report By Test Type (Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test), By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

腦膜炎診斷測試市場的增長和趨勢

根據 Grand View Research, Inc 的最新報告，到 2030 年，全球腦膜炎診斷測試市場規模預計將達到 1.5406 億美元，預測期內的複合年增長率為 3.68%。 市場的增長歸因於公眾對疾病早期診斷意識的提高以及對快速診斷和高精度測試的需求增加。 此外，政府加大對減輕疾病負擔的支持以及診斷中心數量的增加也在推動市場需求。

傳染病和 HIV 的傳播增加了患腦膜炎的風險，增加了全世界對腦膜炎診斷測試的需求。 例如，據世界衛生組織稱，到 2021 年，全世界將有超過 3840 萬人感染艾滋病毒。 此外，根據 CDC 的數據，2020 年美國約有 30,635 人被診斷出患有 HIV，大量 HIV 感染者可能會提高腦膜炎的檢測率。 此外，估計 EV 腦膜炎每年在美國導致大約 30,000 至 50,000 人住院。

相關疾病的高發病率促使製造商開發準確的診斷解決方案。 例如，Cepheid 提供 Xpert EV，這是一種快速分子體外診斷，可在 2.5 小時內提供具有最佳靈敏度和特異性的結果。 同樣，Diagenode Diagnostics 的 M-DiaMult 是一種 PCR-CE-IVD 試劑盒，可檢測多種細菌感染，包括腦膜炎奈瑟菌。

由於其長期影響和高死亡率，腦膜炎是一個全球性問題。 各國政府正在積極支持提供先進的診斷測試和治療以根除腦膜炎。 例如，腦膜炎研究基金會和疾病預防控制中心為許多醫院無法提供的傳染病提供診斷服務，例如肺結核、瘧疾和腦膜炎。 因此，政府促進各種傳染病診斷的努力可能會為市場提供有利可圖的增長機會。

此外，醫療保健行業的迅猛發展和診斷測試技術的不斷進步預計將為市場提供強勁的增長機會。 例如，2022 年 7 月，分子診斷檢測的領導者 Abacus Diagnostica 在歐洲市場推出了一種新的快速 PCR 檢測，用於快速識別引起腦炎和腦膜炎的病毒。 這項新推出的測試使醫療保健專業人員能夠在短短 70 分鐘內識別出引起腦膜炎的最常見病毒。 高精度和快速測試的引入預計將推動未來幾年的市場增長。

腦膜炎診斷測試市場報告要點

由於對 PCR 測試的高度偏好、高靈敏度和低測試周轉時間，PCR 檢測部分在 2022 年佔據了最大的市場份額

隨著快速檢測在各種醫療機構中的持續增長，預計未來幾年橫向流動檢測將以最快的速度增長

醫院部門是基準年銷售額的最大貢獻者，銷售額增加歸因於新診斷技術的普及和健康覆蓋率的提高

由於傳染病的激增和先進產品的日益採用，預計診斷中心部分將呈現最快的增長速度

由於該地區臨床試驗的投資增加和進展，預計亞太地區在預測期內將呈現最快的增長

內容

第1章調查方法及範圍

  • 市場細分和範圍
    • 細分範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析
      • 方法：產品流方法
  • 調查假設
  • 二級信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場展望
  • 競爭考慮

第 3 章腦膜炎診斷測試市場變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場
  • 市場動態
    • 市場驅動因素分析
      • 腦膜炎患病率增加
      • 創新技術對快速診斷的需求不斷增長
      • 政府大力支持控制腦膜炎球菌病爆發
    • 市場製約因素分析
      • 嚴格的監管框架
  • 描繪滲透率和增長前景
  • 腦膜炎診斷測試：市場分析工具
    • 行業分析 - 搬運工
    • PESTLE 分析
  • 監管框架
  • 價格分析

第 4 章。按測試類型分列的腦膜炎診斷測試市場細分分析，2018-2030（百萬美元）

  • 定義和範圍
  • 2022 年和 2030 年測試類型市場份額分析
  • 部門儀表板
  • 2018-2030 年按測試類型分列的全球腦膜炎診斷測試市場
  • 2018-2030 年市場規模和預測、趨勢分析
    • 乳膠絮凝
    • 側流分析
    • PCR 檢測
    • ELISA 測試
    • 文化測試
    • 其他

第 5 章。腦膜炎診斷測試市場細分分析，按最終用戶，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2022 年和 2030 年最終用戶市場份額分析
  • 部門儀表板
  • 全球腦膜炎診斷測試市場，按最終用戶劃分，2018-2030 年
  • 2018-2030 年市場規模和預測、趨勢分析
    • 醫院
    • 診斷中心
    • 其他

第 6 章腦膜炎診斷測試市場細分分析，按地區劃分，2018-2030 年（百萬美元）

  • 定義和範圍
  • 2022 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 區域市場概況
  • SWOT 分析
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2018-2030 年市場規模、預測、收入和趨勢分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 西班牙
      • 法國
      • 意大利
      • 丹麥
      • 瑞典
      • 挪威
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 澳大利亞
      • 泰國
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 多邊環境協定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國
      • 科威特

第 7 章。腦膜炎診斷測試市場 - 競爭分析

  • 主要市場進入者的近期趨勢和影響分析
    • 安索夫矩陣
    • 熱圖分析
    • 主要交易和戰略聯盟分析
      • 合資企業
      • 許可協議
      • 產品發布
      • 會議和活動
  • 公司分類
    • 創新者
    • 市場領導者
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
  • 上市公司
    • 競爭儀表板分析
      • 市場差異化因素
  • 私人公司
    • 主要初創公司名單
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Bio-Rad Laboratories, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 雅培
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • ELI 科技集團
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Seegene 公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Luminex 公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CERTEST BIOTEC
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 伊米
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Unigen 公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68040-009-0

Meningitis Diagnostic Testing Market Growth & Trends:

The global meningitis diagnostic testing market size is expected to reach USD 154.06 million by 2030, according to a new report by Grand View Research, Inc, registering a CAGR of 3.68% over the forecast period. The growth of the market is accredited to the rising awareness among the people about early disease diagnosis and increasing demand for rapid diagnosis coupled with the high accuracy of the test. Moreover, the increasing government support to reduce the burden of disease and the rising number of diagnostic centers are other factors fueling market demand.

The increasing prevalence of infectious diseases, and HIV is increasing the risk of developing meningitis, which is increasing the demand for meningitis diagnostic tests, worldwide. For instance, according to the WHO, over 38.4 million people were living with HIV worldwide in 2021. In addition, according to CDC in 2020, around 30,635 people received HIV diagnoses in the U.S. High number of HIV infections may increase the testing rate for meningitis. Moreover, EV meningitis is estimated to result in around 30,000-50,000 hospitalizations every year in the U.S.

Thus, such a high incidence of target diseases is pushing manufacturers to develop precise diagnostic solutions. For instance, Cepheid offered Xpert EV, a fast molecular in vitro diagnostic EV test, which provides results in 2.5 hours with optimum sensitivity and specificity. Similarly, M-DiaMult of Diagenode Diagnostics is a type of PCR- CE-IVD kit that detects many bacterial infections including Neisseria meningitidis.

Meningitis infection has emerged as a global issue owing to its long-term consequences and high mortality rate. The government is offering active support to provide sophisticated diagnostic tests and treatment regimens to eradicate the disease. For instance, the Meningitis Research Foundation and the CDC offer referral diagnoses for different infectious diseases such as tuberculosis, malaria, and meningitis among others that are not available in hospitals. Thus, such government initiatives to promote the diagnosis of various infectious diseases are likely to offer lucrative growth opportunities for the market.

Furthermore, the surge in the healthcare sector developments and growing technological advancements in diagnostic tests are likely to offer robust growth opportunities for the market. For instance, in July 2022, Abacus Diagnostica, a leader in molecular diagnostic testing, launched a novel rapid PCR test in Europe markets for the quick identification of viruses causing encephalitis and meningitis. This newly launched test allows healthcare professionals to identify the most common virus those causes meningitis in a span of 70 minutes. The introduction of rapid tests with high accuracy is anticipated to propel the market growth in the coming years.

Meningitis Diagnostic Testing Market Report Highlights:

  • PCR assay segment held the largest market share in 2022 owing to a high preference for PCR tests and higher sensitivity and lower turnaround times of the test
  • Lateral flow assay is expected to be the fastest segment during the coming years due to the increasing adoption of rapid tests at different healthcare facilities
  • Hospitals segment was the leading revenue contributor during the base year and its high revenue is attributed to increasing access to novel diagnostic technologies and improved healthcare coverage
  • The diagnostic centers segment is anticipated to exhibit the fastest growth rate owing to the surge in the burden of infectious diseases and the increasing adoption of technologically advanced products
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period due to rising investments in the region and ongoing trials in the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Competitive Insights

Chapter 3 Meningitis Diagnostic Testing Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market
  • 3.2 Market Dynamics
    • 3.2.1 Market drivers analysis
      • 3.2.1.1 Increasing prevalence of meningitis
      • 3.2.1.2 Rise in demand for rapid diagnosis by using innovative technologies
      • 3.2.1.3 Active government support to control meningitis disease outbreak
    • 3.2.2 Market restraint analysis
      • 3.2.2.1 Stringent regulatory framework
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Meningitis Diagnostic Testing: Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
    • 3.4.2 PESTLE analysis
  • 3.5 Regulatory Framework
  • 3.6 Pricing Analysis

Chapter 4 Meningitis Diagnostic Testing Market Segment Analysis, By Test Type, 2018 - 2030 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Test Type Market Share Analysis, 2022 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Meningitis Diagnostic Testing Market, by Test Type, 2018 to 2030
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.5.1 Latex Agglutination
      • 4.5.1.1 Latex agglutination market, 2018 - 2030 (USD million)
    • 4.5.2 Lateral Flow Assay
      • 4.5.2.1 Lateral flow assay market, 2018 - 2030 (USD million)
    • 4.5.3 PCR Assay
      • 4.5.3.1 PCR assay market, 2018 - 2030 (USD million)
    • 4.5.4 ELISA Tests
      • 4.5.4.1 ELISA tests market, 2018 - 2030 (USD million)
    • 4.5.5 Culture Test
      • 4.5.5.1 Culture test market, 2018 - 2030 (USD million)
    • 4.5.6 Others
      • 4.5.6.1 Others market, 2018 - 2030 (USD million)

Chapter 5 Meningitis Diagnostic Testing Market Segment Analysis, By End-User 2018 - 2030 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 End-User Market Share Analysis, 2022 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Meningitis Diagnostic Testing Market, by End-User, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Hospitals
      • 5.5.1.1 Hospitals market, 2018 - 2030 (USD million)
    • 5.5.2 Diagnostic Centers
      • 5.5.2.1 Diagnostic centers market, 2018 - 2030 (USD million)
    • 5.5.3 Others
      • 5.5.3.1 Others market, 2018 - 2030 (USD million)

Chapter 6 Meningitis Diagnostic Testing Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 6.1 Definition & Scope
  • 6.2 Regional Market Share Analysis, 2022 & 2030
  • 6.3 Regional Market Dashboard
  • 6.4 Regional Market Snapshot
  • 6.5 SWOT Analysis
    • 6.5.1 North America
    • 6.5.2 Europe
    • 6.5.3 Asia Pacific
    • 6.5.4 Latin America
    • 6.5.5 Middle East and Africa
  • 6.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
    • 6.6.1 North America
      • 6.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD million)
      • 6.6.1.2 U.S.
      • 6.6.1.2.1 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.1.3 Canada
      • 6.6.1.3.1 Canada meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.2 Europe
      • 6.6.2.1 Europe meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.2 U.K.
      • 6.6.2.2.1 U.K. meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.3 Germany
      • 6.6.2.3.1 Germany meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.4 Spain
      • 6.6.2.4.1 Spain meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.5 France
      • 6.6.2.5.1 France meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.6 Italy
      • 6.6.2.6.1 Italy meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.7 Denmark
      • 6.6.2.7.1 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.8 Sweden
      • 6.6.2.8.1 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.9 Norway
      • 6.6.2.9.1 Norway meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.3 Asia Pacific
      • 6.6.3.1 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.2 Japan
      • 6.6.3.2.1 Japan meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.3 China
      • 6.6.3.3.1 China meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.4 India
      • 6.6.3.4.1 India meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.5 South Korea
      • 6.6.3.5.1 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.6 Australia
      • 6.6.3.6.1 Australia meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.7 Thailand
      • 6.6.3.7.1 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.4 Latin America
      • 6.6.4.1 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.4.2 Brazil
      • 6.6.4.2.1 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.4.3 Mexico
      • 6.6.4.3.1 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.4.4 Argentina
      • 6.6.4.4.1 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.5 MEA
      • 6.6.5.1 MEA meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.2 South Africa
      • 6.6.5.2.1 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.3 Saudi Arabia
      • 6.6.5.3.1 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.4 UAE
      • 6.6.5.4.1 UAE meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.5 Kuwait
      • 6.6.5.5.1 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD million)

Chapter 7 Meningitis Diagnostic Testing Market - Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 7.1.1 Ansoff matrix
    • 7.1.2 Heat map analysis
    • 7.1.3 Major Deals and Strategic Alliances Analysis
      • 7.1.3.1 Joint Ventures
      • 7.1.3.2 Licensing Agreements
      • 7.1.3.3 Product Launches
      • 7.1.3.1 Conferences and Campaigns
  • 7.2 Company Categorization
    • 7.2.1 Innovators
    • 7.2.2 Market Leaders
  • 7.3 Vendor Landscape
    • 7.3.1 List of key distributors and channel partners
    • 7.3.2 Key customers
  • 7.4 Public Companies
    • 7.4.1 Competitive Dashboard Analysis
      • 7.4.1.1 Market Differentiators
  • 7.5 Private Companies
    • 7.5.1 List of key emerging companies
  • 7.6 Company Profiles
    • 7.6.1 Thermo Fisher Scientific, Inc.
      • 7.6.1.1 Company overview
      • 7.6.1.2 Financial performance
      • 7.6.1.3 Product benchmarking
      • 7.6.1.4 Strategic initiatives
    • 7.6.2 Bio-Rad Laboratories, Inc.
      • 7.6.2.1 Company overview
      • 7.6.2.2 Financial performance
      • 7.6.2.3 Product benchmarking
      • 7.6.2.4 Strategic initiatives
    • 7.6.3 Abbott
      • 7.6.3.1 Company overview
      • 7.6.3.2 Financial performance
      • 7.6.3.3 Product benchmarking
      • 7.6.3.4 Strategic initiatives
    • 7.6.4 ELITechGroup
      • 7.6.4.1 Company overview
      • 7.6.4.2 Financial performance
      • 7.6.4.3 Product benchmarking
      • 7.6.4.4 Strategic initiatives
    • 7.6.5 Seegene Inc.
      • 7.6.5.1 Company overview
      • 7.6.5.2 Financial performance
      • 7.6.5.3 Product benchmarking
      • 7.6.5.4 Strategic initiatives
    • 7.6.6 Luminex Corporation
      • 7.6.6.1 Company overview
      • 7.6.6.2 Financial performance
      • 7.6.6.3 Product benchmarking
      • 7.6.6.4 Strategic initiatives
    • 7.6.7 CERTEST BIOTEC
      • 7.6.7.1 Company overview
      • 7.6.7.2 Financial performance
      • 7.6.7.3 Product benchmarking
      • 7.6.7.4 Strategic initiatives
    • 7.6.8 IMMY
      • 7.6.8.1 Company overview
      • 7.6.8.2 Financial performance
      • 7.6.8.3 Product benchmarking
      • 7.6.8.4 Strategic initiatives
    • 7.6.9 Uniogen Oy
      • 7.6.9.1 Company overview
      • 7.6.9.2 Financial performance
      • 7.6.9.3 Product benchmarking
      • 7.6.9.4 Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Meningitis Diagnostic Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 6 Global Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 7 North America Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 9 North America Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 10 U.S. Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 12 Canada Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 13 Canada Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 14 Europe Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 15 Europe Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 16 Europe Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 17 U.K. Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 18 U.K. Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 19 Germany Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 20 Germany Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 21 France Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 22 France Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 23 Spain Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 24 Spain Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 25 Italy Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 26 Italy Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 27 Denmark Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 28 Denmark Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 29 Norway Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 30 Norway Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 31 Sweden Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 32 Sweden Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 36 Japan Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 37 Japan Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 38 China Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 39 China Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 40 India Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 41 India Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 42 Australia Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 43 Australia Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 44 South Korea Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 45 South Korea Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 46 Thailand Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 47 Thailand Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 48 Latin America Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Latin America Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 50 Latin America Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 51 Brazil Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 52 Brazil Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 53 Argentina Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 54 Argentina Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 55 Mexico Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 56 Mexico Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 57 Middle East and Africa Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 58 Middle East and Africa Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 59 Middle East and Africa Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 60 South Africa Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 61 South Africa Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 64 UAE Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 65 UAE Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 67 Kuwait Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Meningitis diagnostic testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2022)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Meningitis Diagnostic Testing market: Test type movement analysis
  • Fig. 17 Meningitis Diagnostic Testing market: Test type segment dashboard
  • Fig. 18 Meningitis Diagnostic Testing market Test type outlook: Key takeaways
  • Fig. 19 Latex agglutination market, 2018 - 2030 (USD million)
  • Fig. 20 Lateral flow assay market, 2018 - 2030 (USD million)
  • Fig. 21 PCR assay market, 2018 - 2030 (USD million)
  • Fig. 22 ELISA tests market, 2018 - 2030 (USD million)
  • Fig. 23 Culture test market, 2018 - 2030 (USD million)
  • Fig. 24 Others market, 2018 - 2030 (USD million)
  • Fig. 25 Meningitis Diagnostic Testing market: End-user analysis
  • Fig. 26 Meningitis Diagnostic Testing market: End-user segment dashboard
  • Fig. 27 Meningitis Diagnostic Testing market End-user outlook: Key takeaways
  • Fig. 28 Hospitals market, 2018 - 2030 (USD million)
  • Fig. 29 Diagnostic centers market, 2018 - 2030 (USD million)
  • Fig. 30 Others market, 2018 - 2030 (USD million)
  • Fig. 31 Regional outlook, 2022 & 2030
  • Fig. 32 Regional market dashboard
  • Fig. 33 Regional market place: Key takeaways
  • Fig. 34 North America, SWOT
  • Fig. 35 Europe, SWOT
  • Fig. 36 Asia Pacific, SWOT
  • Fig. 37 Latin America, SWOT
  • Fig. 38 Middle East and Africa, SWOT
  • Fig. 39 North America
  • Fig. 40 North America meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 41 U.S.
  • Fig. 42 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 43 Canada
  • Fig. 44 Canada meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 45 Europe
  • Fig. 46 Europe meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 47 U.K.
  • Fig. 48 U.K. meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 49 Germany
  • Fig. 50 Germany meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 51 Spain
  • Fig. 52 Spain meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 53 France
  • Fig. 54 France meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 55 Italy
  • Fig. 56 Italy meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 57 Denmark
  • Fig. 58 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 59 Sweden
  • Fig. 60 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 61 Norway
  • Fig. 62 Norway meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 63 Asia Pacific
  • Fig. 64 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 65 Japan
  • Fig. 66 Japan meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 67 China
  • Fig. 68 China meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 69 India
  • Fig. 70 India meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 71 South Korea
  • Fig. 72 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 73 Australia
  • Fig. 74 Australia meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 75 Thailand
  • Fig. 76 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 77 Latin America
  • Fig. 78 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 79 Brazil
  • Fig. 80 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 81 Mexico
  • Fig. 82 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 83 Argentina
  • Fig. 84 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 85 Middle East and Africa
  • Fig. 86 MEA meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 87 South Africa
  • Fig. 88 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia
  • Fig. 90 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 91 UAE
  • Fig. 92 UAE meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 93 Kuwait
  • Fig. 94 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 95 Ansoff Matrix
  • Fig. 96 Heat map analysis
  • Fig. 97 Market differentiators